Search clinical trials for: Placebo Comparator: 3M™ Tegaderm™ I.V. Advanced Dressing

Total 62 results

University Hospital, Basel, Switzerland

Completed

Prospective Randomised Study for Use of CHG Dressing at Entry Site of EVD's to Reduce EVD-associated Infections (EVDAI)

Wound Contamination

Switzerland
3M

Terminated

Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy

Catheter-Related Infections | Central Venous Catheter Exit Site Infection

China
University of Cologne
3M

Completed

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients (COAT)

Bloodstream Infection

Germany
University Hospital, Grenoble

Completed

Comparison of Two New Generation Dressings in Intensive Care (ADVANCED) (ADVANCED)

Complication of Catheter

France
University of Sao Paulo

Unknown

Chlorhexidine-Impregnated Sponge Dressing: A Clinical Trial (CISDCT)

Catheter-Related Infections

Brazil
The University of Queensland
Queensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaborators

Recruiting

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) (ProP)

Wound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site Reactions

Australia, France
NYU Langone Health

Withdrawn

The Efficacy of Chlorhexidine Gluconate Gel Dressing in Preventing Surgical Drain Site Infection

Drain Site Complication

United States
Covalon Technologies Inc.

Completed

Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth

Skin Flora Infection

United States
Covalon Technologies Inc.

Completed

Human Repeat Insult Patch Test of Wound Dressings

Skin Sensitization

United States
Loma Linda University

Withdrawn

A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites (OASIS)

Skin Graft Complications
3M

Completed

A Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis

Plaque

United States
Thomas Jefferson University
Acelity

Recruiting

Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications (PREVENA-AMP)

Amputation | Seroma | Wound Infection, Surgical | Wound Dehiscence | Lymph Leakage | Amputation; Postoperative, Sequelae

United States, Italy
Mayo Clinic

Completed

3M Cavilon Advanced Skin Protectant for the Prophylaxis of Radiation Dermatitis

Radiation Dermatitis

United States
Medline Industries

Completed

Durability of Two Skin Barrier Protectants (SBP)

Skin Hydration in Healthy Volunteers

United States
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults

Influenza

Sweden
Merck Sharp & Dohme LLC

Completed

Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)

Gastroenteritis | Rotavirus
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Shingles
3M

Recruiting

Evaluating the Efficacy and Safety of the VERAFLO™ Dressing Kit for Wound Bed Preparation in Open Wounds

Wound Healing

China
Merck Sharp & Dohme LLC

Completed

Developing World Study for RotaTeq™ (V260-015)(COMPLETED)

Vomiting | Diarrhea | Fever
Merck Sharp & Dohme LLC

Completed

A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Papillomavirus Infections | Human
Unity Health Toronto

Recruiting

A Non-Traumatic Binder for Temporary Abdominal Wall Closure (ABRO)

Peritonitis | Abdominal Abscess | Abdominal Injury | Abdominal Trauma | Abdominal Sepsis | Abdominal Aneurysm | Abdominal Compartment Syndrome | Abdominal Infection

Canada
Merck Sharp & Dohme LLC

Completed

Rotavirus Efficacy and Safety Trial (REST)(V260-006)

Rotavirus Infections
Merck Sharp & Dohme LLC

Completed

Dose Confirmation Efficacy Study (V260-007)

Rotavirus Infections
Ethos Research & Development
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Evaluate the Use of the Foundation Pain Index and the Nutritional Supplement BioPlete™ in Adults With Chronic Pain

Chronic Pain

United States
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

Herpes Zoster
NovaRx Corporation

Completed

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy (STOP)

Lung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IV

United States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
3M
KCI Europe Holding B.V.

Terminated

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

Wound Infection | Surgical Site Occurences After Sternotomy

Germany, Netherlands, Austria
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

Herpes Zoster | Pneumococcal Infection
Merck Sharp & Dohme LLC

Completed

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

Rotavirus Gastroenteritis
Sunnybrook Health Sciences Centre

Completed

Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) (FiiRST)

Bleeding | Trauma | Coagulopathy | Injury | Haemorrhage

Canada
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

Influenza, Human

Sweden
University of Nottingham
National Institute for Health Research, United Kingdom

Completed

Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea (RAPID)

Clostridium Difficile Infection

United Kingdom
Merck Sharp & Dohme LLC

Completed

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

HPV Infections
Merck Sharp & Dohme LLC

Completed

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

Condylomata Acuminata
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Herpes Zoster
Assistance Publique - Hôpitaux de Paris
AstraZeneca

Recruiting

DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction (DAPAPROTECTOR)

STEMI | Left Ventricular Dysfunction | NSTEMI | AMI

France
Damascus University

Completed

Effect of Tri Calcium Phosphate on Efficacy and Sensitivity With Vital Tooth Whitening Using 20% Carbamide Peroxide

Tooth Sensitivity

Syrian Arab Republic
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

Type 2 Diabetes Mellitus
QED Therapeutics, Inc.

Enrolling by invitation

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia (PROPEL3)

Achondroplasia

Australia, United States, Argentina, Canada, France, Germany, Italy, Norway, Singapore, Spain, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

HIV Infections
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)

HIV Infections
Merck Sharp & Dohme LLC

Completed

Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

Sitagliptin Added-on to Insulin Study (0431-051)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)

Diabetes Mellitus Type 2
AstraZeneca

Completed

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Type 2 Diabetes Mellitus, CKD and Albuminuria

United States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
Merck Sharp & Dohme LLC

Completed

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Cytomegalovirus Infection

United States, France, Germany, Italy, Japan, United Kingdom
Merck Sharp & Dohme LLC

Terminated

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

HIV Infection
ZARS Pharma Inc.

Completed

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children

Pain

United States

3

Subscribe